Esteban Fomperosa - Hypera SA Member of the Board of Directors
| HYPE3 Stock | BRL 19.52 0.13 0.66% |
Director
Mr. Esteban Malpica Fomperosa serves as a Member of the Board of Directors of Hypermarcas SA. Since 2004, he was Managing Partner of Praemia SC. He is Member of the Board of Directors of several companies in Mexico, including El Puerto de Liverpool SAB de CV, Kimberly Clark de Mexico SAB de CV, Gruma SAB de CV and Empresas ICA SAB de CV. From 1995 to 2001, he served as Executive Vice President of the Banamex Financial Group, Accival SA de CV. From 1992 to 1995, he acted as Executive Vice President of the Mexican Stock Exchange and Chairman of the Board of Directors of the Mexico Equity Income Fund. From 1978 to 1995, he worked at Acciones y Valores de Mexico. He gained a Bachelors in Public Accounting from Universidad Iberoamericana in 1971 and a Masters of Business Administration from University of Notre Dame du Lac in 1974.
| Age | 70 |
| Phone | 55 11 3627 4206 |
| Web | https://www.hyperapharma.com.br |
Hypera SA Management Efficiency
The company has return on total asset (ROA) of 0.0686 % which means that it generated a profit of $0.0686 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1626 %, meaning that it generated $0.1626 on every $100 dollars invested by stockholders. Hypera SA's management efficiency ratios could be used to measure how well Hypera SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | DIRECTOR Age | ||
| Maria Costa | Localiza Rent a | 58 | |
| Rosangela Souza | Qualicorp Consultoria e | N/A | |
| Samuel Santos | Fleury SA | 73 | |
| Jeane Tsutsui | Fleury SA | N/A | |
| Claudio Prado | Fleury SA | 55 | |
| Wilson Olivieri | Qualicorp Consultoria e | 60 | |
| Maria Souza | Raia Drogasil SA | 53 | |
| Renato Raduan | Raia Drogasil SA | 42 | |
| Alexandre Dias | Qualicorp Consultoria e | 47 | |
| Paulo Veras | Localiza Rent a | 42 | |
| Jose Araujo | Fleury SA | N/A | |
| Andrea Chamma | Fleury SA | N/A | |
| Edgar Rizzatti | Fleury SA | N/A | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0686 |
Hypera SA Leadership Team
Elected by the shareholders, the Hypera SA's board of directors comprises two types of representatives: Hypera SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hypera. The board's role is to monitor Hypera SA's management team and ensure that shareholders' interests are well served. Hypera SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hypera SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Juliana Salem, Legal Officer | ||
| Breno Oliveira, Investor Relations Officer, Member of the Executive Board | ||
| Luciana Queiroz, Member of the Board of Directors | ||
| Maria Lacerda, Independent Member of the Board of Directors | ||
| David Neto, Independent Member of the Board of Directors | ||
| David Coury, Independent Member of the Board of Directors | ||
| Rafael Batista, Executive Officer | ||
| Adalmario Couto, Chief Financial Officer, Investor Relations Officer, Business Development Officer | ||
| Flair Carrilho, Independent Member of the Board of Directors | ||
| Alvado Link, Member of the Board of Directors | ||
| Hlio Segouras, Head Health | ||
| Hugo Leal, Member of the Board of Directors | ||
| Joao Aguilar, Risks Officer | ||
| Mauricio Christovam, HR Officer | ||
| Nelson Mello, Institutional Relations Officer, Member of the Executive Board | ||
| Bernardo Hernandez, Member of the Board of Directors | ||
| Vivian Angiolucci, Chief Operating Officer, Member of the Executive Board | ||
| Carlos Scorsi, COO, Member of the Executive Board | ||
| Luiz Clavis, Commercial and Marketing Vice President | ||
| Martim Mattos, Chief Financial Officer, Chief Controllership Officer, Member of the Executive Board | ||
| Esteban Fomperosa, Member of the Board of Directors |
Hypera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hypera SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0686 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 33.47 B | |||
| Shares Outstanding | 631.94 M | |||
| Shares Owned By Insiders | 36.24 % | |||
| Shares Owned By Institutions | 40.62 % | |||
| Price To Earning | 13.10 X | |||
| Price To Book | 2.55 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hypera Stock Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.